MS

Multiple Sclerosis Journal

Multiple Sclerosis Journal is a peer-reviewed international journal focused on all aspects of multiple sclerosis, neuromyelitis optica, and other related autoimmune diseases of the central nervous system, including biologic basis, epidemiology and genetics, and clinical and neuroimaging research.

Looking to publish in Multiple Sclerosis Journal? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Existing customer login
Subject Clinical Neurology, Neurosciences
Impact Factor 5
Quartile Q1
Open Access Type Hybrid
ISSN 1352-4585
eISSN 1477-0970
Invitation Only No
Cost Range Title-specific APCs apply under the Sage Choice program; pricing varies by journal and may exclude other journal-specific fees.

Submission Instructions

Multiple Sclerosis Journal accepts the following article types. Click on an article type to view submission instructions.

Original Research Paper

Cover Letter Covering letter must disclose any writing or editing assistance from a third party and whether the submission was made by someone not listed as an author.
Abstract Abstract is required. Abstract must be 200 words. Abstract must be structured. Abstract must concisely state the purpose of the research, major findings, and conclusions, include numerical results, and the results section should report point estimates and confidence intervals of the primary analysis.
Manuscript Manuscript must not exceed 3,000 words excluding references, tables, and legends. Manuscript must contain the following sections: Title page, Abstract, Introduction, Materials (or patients or animals) and Methods, Results, Discussion, Acknowledgements, References, Tables, Figure legends, and Figures. Manuscript must include at least 5 keywords after the abstract and a section headed 'Statements and Declarations' at the end of the article after the Acknowledgements section and Author Contributions section if applicable, with all required subheadings included even when marked 'Not applicable,' and AI usage must be disclosed in the Acknowledgements or Methodology section when required by the journal's AI use policy.
References Submission may include up to 35 references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, and corresponding citations must have identical spelling and year.
Figures & Tables Submission may include a maximum of 8 figures or tables. Tables and figures must not be embedded within the main text. Figures must be numbered consecutively in the order they appear in the text.
Reformat to Multiple Sclerosis Journal using Livewrite Premium

Topical Review

Cover Letter Writing or editing assistance from a third party and submission by someone not listed as an author must be disclosed in the covering letter.
Abstract Abstract is required. Abstract must be 150 words. Abstract must be unstructured.
Manuscript Main text must be 2,500 words excluding references. Manuscript must include a title page, abstract, main text, Statements and Declarations section, and references. Manuscript must include 5 keywords after the abstract and a section headed 'Statements and Declarations' at the end of the article.
References Reference list may include up to 35 references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and every reference list entry must be cited in the text.
Figures & Tables A maximum of eight figures or tables is allowed. Tables and figures must not be embedded within the main text. Figures must be numbered consecutively in the order cited, and tables must be editable text with a number and title.
Reformat to Multiple Sclerosis Journal using Livewrite Premium

Reviews

Cover Letter Covering letter must disclose any third-party writing or editing assistance and whether submission was made by someone not listed as an author.
Abstract A structured abstract is required. Abstract must be 200 words. Abstract must be structured.
Manuscript Main manuscript document must include a title page, abstract, main text, end statements, and references. Include at least 5 keywords after the abstract and a 'Statements and Declarations' section at the end of the article with all required subheadings, including 'Not applicable' where relevant.
References References must use Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, with identical spelling and year in corresponding citations.
Figures & Tables Tables and figures must not be embedded within the main text. Figures must be numbered consecutively in the order cited, and tables must be labeled as tables with a number and title and include a header row and/or column.
Reformat to Multiple Sclerosis Journal using Livewrite Premium

Short Report

Cover Letter Writing or editing assistance from a third party and submission by someone not listed as an author must be disclosed in the covering letter.
Abstract Abstract is required. Abstract must be 100 words. Abstract must be structured.
Manuscript Main text must be less than 1,000 words, excluding references, tables, and legends. Main manuscript document must comprise a title page, abstract, main text, end statements, and references. Include at least 5 keywords after the abstract and a 'Statements and Declarations' section at the end of the article, and disclose AI usage in the Acknowledgements or Methodology section when applicable.
References Reference list must contain no more than 10 references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, and corresponding citations must have identical spelling and year.
Figures & Tables Submission may include a maximum of two figures or tables. Tables and figures must not be embedded within the main text. All figures must be numbered consecutively in the order cited, and tables must be labeled as tables with a number and title and provided as editable text rather than images.
Reformat to Multiple Sclerosis Journal using Livewrite Premium

Case Report

Cover Letter Writing or editing assistance from a third party and submission by someone not listed as an author must be disclosed in the covering letter.
Abstract A short summary is required. The short summary must not exceed 100 words.
Manuscript Case Report submissions must not exceed 1,000 words. The submission must have a title page. The manuscript must include a 'Statements and Declarations' section at the end of the article, include at least 5 keywords after the abstract, and disclose AI use in the Acknowledgements or Methodology section when required by the journal's AI use policy.
References Case Report submissions may include up to 10 references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and vice versa, with identical spelling and year in corresponding citations.
Figures & Tables Case Report submissions may include up to two figures or tables. Tables and figures must not be embedded within the main text. Figures must be numbered consecutively in the order cited, and tables must be labeled as tables with a number and title.
Reformat to Multiple Sclerosis Journal using Livewrite Premium

Letter To The Editor

Cover Letter Covering letter must disclose any third-party writing or editing assistance and whether the submission was made by someone not listed as an author.
Abstract Abstract must not be included.
Manuscript Main text must not exceed 500 words, excluding references, tables, and legends. Manuscript must be presented in letter format without an abstract. A 'Statements and Declarations' section must be included at the end of the article, and a minimum of 5 keywords must be listed after the abstract, although this article type does not include an abstract.
References Reference list may include up to 10 references. References must follow Sage Vancouver style. Every in-text citation must have a corresponding reference list entry and every reference list entry must be cited in the text.
Figures & Tables Tables and figures must not be embedded within the main text, except figures and tables created in Word should be included in the main text rather than at the end of the document. Figures must be numbered consecutively in the order cited, and tables must be labeled as tables with a number and title.
Reformat to Multiple Sclerosis Journal using Livewrite Premium

Recent Publications

Affective reserve in older adults with and without multiple sclerosis: A residual-based approach

Elizabeth S. Gromisch, Frederick W. Foley, Mark E. Wagshul, Roee Holtzer

10.1177/13524585261480508
View Publication

Persistent differences in initial diagnostic trajectory for Black and Hispanic individuals presenting with multiple sclerosis between 2020 and 2023

Serena Gilmore, Shane Poole, Kyra Henderson, Nikki Sisodia, Jaeleene Wijangco, Chu-Yueh Guo, Lilyana Amezcua, Riley Bove

10.1177/13524585261475041
View Publication

Implementation of a pilot online educational program to identify paramagnetic rim lesions

Richa Thakkar, Elizabeth Silbermann, Francesca Bagnato, Dennis Bourdette, Christopher C. Hemond, William Rooney, Andrew J. Solomon, Lindsey Wooliscroft, Chris Hollen

10.1177/13524585261476513
View Publication

A community-validated tool for clinical outcome calculation in multiple sclerosis: Consensus development and scenario-specific recommendations

Noemi Montobbio, Francesca Bovis, Lisa Hofer, Dieter A. Häring, Pascal Benkert, Carmen Tur, Tomas Kalincik, Sifat Sharmin, Ariadna Masot Llima, Daniel Hernández Soria, Amber Salter, Istvan Morocz, Qing Wang, Jens Kuhle, Steven Chappell, Ruggero Capra, Cinzia Cordioli, Marcus D’Souza, Timothy Coetzee, Xavier Montalban, Douglas L. Arnold, Peter A. Calabresi, Maria P. Sormani

10.1177/13524585261478492
View Publication

Taking another look: LBSL diagnosed in adulthood masquerading as multiple sclerosis

Carol Swetlik, Sumit Parikh, Aaron Abrams, Kriti Bhayana, Chintan Shah, Kedar R Mahajan

10.1177/13524585261477212
View Publication

Frequently asked questions

How long does it take to publish?

Median time to first decision is 9 days, median time in peer review is 27 days, median time from submission to acceptance is 87 days, and median time from acceptance to online publication is 46 days.

Reformat to Multiple Sclerosis Journal using Livewrite Premium

Is a cover letter required?

A covering letter is required when third-party writing or editing assistance is involved or when a submission is made on behalf of the authors by a non-author.

Reformat to Multiple Sclerosis Journal using Livewrite Premium

What are the publication costs?

Title-specific APCs apply for hybrid open access under Sage Choice; pricing varies by journal.

Reformat to Multiple Sclerosis Journal using Livewrite Premium

Research Topics

Multiple Sclerosis Research Studies Peripheral Neuropathies and Disorders Polyomavirus and related diseases Systemic Sclerosis and Related Diseases Systemic Lupus Erythematosus Research Amyotrophic Lateral Sclerosis Research Rheumatoid Arthritis Research and Therapies Long-Term Effects of COVID-19 Fibromyalgia and Chronic Fatigue Syndrome Research Neuroinflammation and Neurodegeneration Mechanisms Advanced Neuroimaging Techniques and Applications Neurogenesis and neuroplasticity mechanisms Immunotherapy and Immune Responses Diverse Scientific and Economic Studies Viral Infections and Immunology Research T-cell and B-cell Immunology Epilepsy research and treatment Autoimmune and Inflammatory Disorders Research Cytokine Signaling Pathways and Interactions Health Systems, Economic Evaluations, Quality of Life Human auditory perception and evaluation Balance, Gait, and Falls Prevention Autoimmune Neurological Disorders and Treatments Advanced MRI Techniques and Applications Reproductive System and Pregnancy

Related Journals

JO
Journal of Neurology Springer Science+Business Media
Ne
Neuroendocrinology Karger Publishers
TL
The Lancet Neurology Elsevier BV
PR
Pain Research and Management Hindawi Publishing Corporation
FI
Frontiers in Neurorobotics Frontiers Media
TN
Translational Neurodegeneration BioMed Central